Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention

Published:2015 Issue:6 Volume:22 Page:557-569
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kimura Takeshi¹,Isshiki Takaaki²,Ogawa Hisao³,Yokoi Hiroyoshi⁴,Yamaguchi Tetsu⁵,Ikeda Yasuo⁶

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

2. Division of Cardiology, Teikyo University Hospital

3. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, and National Cerebral and Cardiovascular Center

4. Fukuoka Sanno Hospital, Fukuoka, and International University of Health and Welfare

5. Toranomon Hospital

6. Life Science & Medical Bioscience, Faculty of Science and Engineering, Waseda University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Reference19 articles.

1. 1) Lewis HD Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE 3rd, Schnaper HW, LeWin er MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med, 1983; 309: 396-403

2. 2) Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group: Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet, 2005; 366: 1607-1621

3. 3) Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E; CLARITYTIMI 28 Investigators: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med, 2005; 352: 1179-1189

4. 4) Mehta SR, Yusuf S: Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol, 2003; 41: 79S-88S

5. 5) Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ: Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol, 2005; 45: 246-251

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Act　― Prasugrel’s Efficacy and Safety in Japanese Patients Undergoing Percutaneous Coronary Intervention ―;Circulation Journal;2024-09-03

2. Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention;Journal of Cardiology;2023-09

3. Clinical Efficacy and Safety of Reduced-Dose Prasugrel versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;ACTA CARDIOL SIN;2022

4. Comparative Safety and Effectiveness of Loading Doses of P2Y12 Inhibitors in Patients Undergoing Elective PCI: a Network Meta-analysis;Cardiovascular Drugs and Therapy;2021-10-13

5. Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention;International Journal of Cardiology;2021-03